Prostate cancer
Sequencing treatments in mCRPC patients without HRR gene mutationsCase 3: Rui
Rui, 69 years old, has a history of PCa.
Medical history:
- Diagnosed with high-volume mHSPC 1 year ago
- PSA: 63 ng/ml
- Bone and CT scan: multiple bone metastases
- Treatment with ADT + docetaxel + darolutamide was started
- After 6 cycles of docetaxel, his PSA dropped to 2 ng/ml
- Current situation, 6 months after stopping docetaxel, treatment with darolutamide is still ongoing:
- No comorbidities
- No relevant family history
- ECOG PS: 0
- Asymptomatic
- Rising PSA: 13 ng/ml
- Testosterone: 17 ng/dl (0.6 nmol/L)
- Bone and CT scan: 3 new bone metastases, not present on scans 6 months ago, few enlarged pelvic lymph nodes (all <3 cm)
- PSMA-PET/CT: concordant with bone and CT scan, all lesions PSMA positive and higher PSMA expression than liver
- No actionable germline or somatic mutations detected